Chinese biopharma CStone Pharmaceuticals today announced a strategic commercialization partnership with SteinCares, which will gain the commercialization rights for sugemalimab in 10 Latin America ...
Located in Colombia, Costa Rica, Ecuador, and Guatemala, the hubs were part of an initiative aimed at deterring migrants from crossing the southern border illegally ...